Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment
Bin Li,1 Zhongyin Jiang,1 Diya Xie,1 Yiqing Wang,1 Xingzhen Lao2 1Department of Biomedical Engineering, College of Engineering and Applied Sciences, Nanjing University, Nanjing, Jiangsu Province 210093, China; 2Department of Microbial and Biochemical Pharmacy, School of Life Science and Technology,...
Saved in:
Main Authors: | Li B, Jiang Z, Xie D, Wang Y, Lao X |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/a5164026982d4aaf8289ba99fcb873be |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin
by: Elli Narvi, et al.
Published: (2018) -
An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report
by: Tian Fang, et al.
Published: (2021) -
Gold nanoparticles affect the antioxidant status in selected normal human cells
by: Daems N, et al.
Published: (2019) -
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities
by: Biffi S, et al.
Published: (2016) -
In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts
by: Sreeranganathan M, et al.
Published: (2017)